Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2025-02-13 2:26 pm Purchase | 2024-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | BML Investment Partners, L.P. | 14,250,000 13.300% | 4,854,066![]() (+51.66%) | Filing History |
2025-02-12 09:31 am Purchase | 2024-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | Adage Capital Management L.P. | 9,627,304 9.000% | 9,627,304![]() (New Position) | Filing History |
2024-11-25 11:02 am Purchase | 2024-11-18 | 13G | Aclaris Therapeutics, Inc. ACRS | Biosion Inc. | 11,281,985 9.500% | 11,281,985![]() (New Position) | Filing History |
2024-11-22 4:00 pm Purchase | 2024-11-18 | 13G | Aclaris Therapeutics, Inc. ACRS | Rock Springs Capital Management LP | 6,761,861 6.320% | 3,763,366![]() (+125.51%) | Filing History |
2024-11-21 4:51 pm Purchase | 2024-11-19 | 13G | Aclaris Therapeutics, Inc. ACRS | Vivo Opportunity Fund Holdings L.P. | 7,955,160 7.400% | 7,955,160![]() (New Position) | Filing History |
2024-11-14 4:14 pm Sale | 2024-09-30 | 13G | Aclaris Therapeutics, Inc. ACRS | Citadel Advisors LLC | 368,067 0.500% | -5,038,022![]() (-93.19%) | Filing History |
2024-10-09 4:18 pm Sale | 2024-09-30 | 13G | Aclaris Therapeutics, Inc. ACRS | MILLENNIUM MANAGEMENT LLC | 3,005,598 4.200% | -764,328![]() (-20.27%) | Filing History |
2024-07-08 4:32 pm Sale | 2024-06-30 | 13G | Aclaris Therapeutics, Inc. ACRS | BlackRock Inc. BLK | 2,032,464 2.900% | -3,873,408![]() (-65.59%) | Filing History |
2024-02-14 8:32 pm Sale | 2023-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | Venrock Healthcare Capital Partners II, L.P. | 0 0.000% | -4,563,962![]() (Position Closed) | Filing History |
2024-02-14 5:01 pm Sale | 2023-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | RA Capital Management, L.P. | 0 0.000% | -4,398,453![]() (Position Closed) | Filing History |
2024-02-14 4:58 pm Purchase | 2023-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | Citadel Advisors LLC | 5,406,089 7.600% | 1,819,325![]() (+50.72%) | Filing History |
2024-02-14 4:13 pm Purchase | 2024-02-05 | 13G | Aclaris Therapeutics, Inc. ACRS | MILLENNIUM MANAGEMENT LLC | 3,769,926 5.300% | 290,565![]() (+8.35%) | Filing History |
2024-02-14 4:00 pm Sale | 2023-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | TANG CAPITAL MANAGEMENT, LLC | 1,753,335 2.500% | -2,584,820![]() (-59.58%) | Filing History |
2024-02-14 2:06 pm Sale | 2023-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | Rock Springs Capital Management LP | 2,998,495 4.230% | -962,754![]() (-24.30%) | Filing History |
2024-02-14 10:30 am Sale | 2023-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -3,360,941![]() (Position Closed) | Filing History |
2024-02-13 4:55 pm Purchase | 2023-12-29 | 13G | Aclaris Therapeutics, Inc. ACRS | VANGUARD GROUP INC | 4,721,887 6.670% | 4,721,887![]() (New Position) | Filing History |
2024-02-13 2:24 pm Sale | 2023-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | Foresite Capital Fund IV, L.P. | 0 0.000% | -4,066,277![]() (Position Closed) | Filing History |
2024-02-08 11:14 am Purchase | 2024-02-07 | 13G | Aclaris Therapeutics, Inc. ACRS | BML Investment Partners, L.P. | 9,395,934 13.300% | 4,895,934![]() (+108.80%) | Filing History |
2024-02-01 4:15 pm Sale | 2023-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | MILLENNIUM MANAGEMENT LLC | 3,479,361 4.900% | -108,753![]() (-3.03%) | Filing History |
2024-01-25 4:59 pm Purchase | 2023-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | BlackRock Inc. BLK | 5,905,872 8.300% | 818,437![]() (+16.09%) | Filing History |